Skip to main content

Table 1 MR results for plasma and CSF proteins significantly associated with asthma after

From: Potential drug targets for asthma identified through mendelian randomization analysis

Tissue

Protein

UniProt ID

SNPa

Effect

allele

OR

(95% CI)b

P value

PVE

F

statistics

Author

Plasma

IL1R1

P14778

rs7588201

A

1.30 (1.20, 1.42)

1.63E-09

1.21%

39.3

Emilsson

Plasma

IL7R

P16871

rs11957503

G

1.07 (1.04, 1.11)

7.48E-06

8.69%

94.74

Suhre

Plasma

ECM1

Q16610;A0A140VJI7

rs13294

A

1.03 (1.02, 1.05)

2.92E-05

36.97%

584.28

Suhre

Plasma

CD200R1

Q8TD46

rs6791672

A

1.18 (1.09, 1.27)

1.74E-05

1.45%

48.72

Sun

Plasma

ADAM19

Q9H013

rs7728609

C

0.87 (0.82, 0.92)

6.17E-07

2.72%

89.52

Emilsson

CSF

IL-6 sRa

P08887

rs4129267

T

1.29 (1.15, 1.45)

1.93E-05

36.34%

476.66

Yang

CSF

Layilin

Q6UX15

rs674230

G

0.61 (0.51, 0.73)

1.14E-07

14.18%

137.92

Yang

  1. Bonferroni correction
  2. PVE = proportion of variance explained
  3. aAll SNPs used were cis-acting
  4. bOdds ratios for increased risk of asthma were expressed as per SD increase in plasma protein levels and per 10-fold increase in CSF protein levels